Table 2.
Clinical characteristics of patients with ARDS and following ECMO therapy at time of CT examination.
| Characteristics | All patients | ECMO therapy | Non-ECMO therapy | p-Value |
|---|---|---|---|---|
| Number | 23 | 12 | 11 | NS |
| Survivors | 14 | 6 | 8 | NS |
| Age | 42.2 ± 16.38 | 42.66 ± 15.98 | 41.69 ± 17.58 | NS |
| Sex | ||||
| Male | 16 | 7 | 9 | NS |
| Female | 7 | 5 | 2 | NS |
| Time from onset (days) | 3.55 ± 2.1 | 3.71 ± 3 | 3.46 ± 1.5 | NS |
| Chronic lung disease | 3 | 3 | 0 | NS |
| Pregnancy | 3 | 2 | 1 | NS |
| HIV | 1 | 1 | 0 | NS |
| Common variable immunodeficiency | 1 | 1 | 0 | NS |
| Chronic lymphatic leukemia | 2 | 2 | 0 | NS |
| CT score | 103.91 ± 24.04 | 115 ± 19.56 | 91.82 ± 23.29 | p = 0.022 |
| Distribution of findings | ||||
| Diffuse | 17 | 8 | 9 | NS |
| Dorsal | 6 | 4 | 2 | NS |
| SAPS II | 54.73 ± 17.32 | 54.83 ± 17.17 | 55.8 ± 18.36 | NS |
| SOFA | 12.41 ± 3.13 | 13.83 ± 3.33 | 10.7 ± 1.83 | p = 0.013 |
| APACHE II | 26.77 ± 10.3 | 27.25 ± 10.83 | 26.2 ± 10.16 | NS |
| Murray | 3.43 ± 0.42 | 3.69 ± 0.26 | 3.13 ± 0.38 | p = 0.002 |
| P/F ratio (paO2/FiO2) | 91.34 ± 45.22 | 66.83 ± 20.99 | 118.08 ± 50.07 | p = 0.004 |
| P/F score (oxygenation index) | 3.59 ± 0.67 | 3.83 ± 0.39 | 3.3 ± 0.82 | p = 0.077 |